COMP <GO>
EMR vs SPCX // GROSS PROFIT MARGIN
Emerson Electric Company (NYSE) VS. Space Exploration Technologies Corp. (NASDAQ) • 15-METRIC TALLY: EMR 2
— SPCX 10
■ METRIC PARITY
LAST: $165.96 (+0.62%) • MKT CAP: $92.00B
gross-margins
52.80%
LAST: $136.37 (+1.23%) • MKT CAP: $1.83T
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMR VS. SPCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMR | SPCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 52.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.70% | 58.30% | -48.60 | SPCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 30.9x | 14.3x | +16.60 | SPCX | /valuation <GO> |
| Free Cash Flow Yield | 2.80% | 3.99% | -1.19 | SPCX | /fcf-yield <GO> |
| Operating Margin | 15.50% | 21.10% | -5.60 | SPCX | /operating-margins <GO> |
| Net Profit Margin | 12.70% | 16.40% | -3.70 | SPCX | /net-margins <GO> |
| Revenue Growth (YoY) | 3.00% | 20.90% | -17.90 | SPCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.25% | 0.00% | +1.25 | EMR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.80 | 26.00 | -21.20 | SPCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.3 | 39.5 | +13.80 | EMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.34 | 1.36 | -0.02 | SPCX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 38.6x | 18.2x | +20.40 | SPCX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $92.00B | $1.83T | -$1.74T | SPCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMR REV | SPCX REV | EMR GROSS % | SPCX GROSS % | EMR FCF | SPCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.02B | $38.67B | 52.8% | — | $2.67B | $0 |
| FY 2024 | $17.49B | — | 50.8% | — | $2.91B | — |
| FY 2023 | $15.16B | — | — | — | -$45.4M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMR // BETA 1.34
SPCX // BETA 1.36